Meetings:

Federal Register: January 4, 2011 (Volume 76, Number 2)

Notices

Page 369

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr04ja11-69

Page 369

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5

U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, NST-1 Subcommittee.

Date: January 31-February 1, 2011.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites Hotel, 1250 22nd Street, NW., Washington,

DC 20037.

Contact Person: Raul A. Saavedra, PhD, Scientific Review

Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience

Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892-9529. 301-496-9223. saavedrr@ninds.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853,

Clinical Research Related to Neurological Disorders; 93.854,

Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated: December 27, 2010.

Anna P. Snouffer,

Deputy Director, Office of Federal Advisory Committee Policy.

FR Doc. 2010-33230 Filed 1-3-11; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT